The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.55
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.10 (18.182%)
Open: 0.60
High: 0.00
Low: 0.00
Prev. Close: 0.60
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Provexis Raises GBP50,000 To Support International Growth Plans

Fri, 19th Feb 2021 10:34

(Alliance News) - Provexis PLC on Friday said it has raised GBP50,000 through the placing of 6.7 million shares at 0.75 pence each.

The placing price represents a 7.4% discount to the Thursday closing price of 0.81p. Shares in the food technology company were trading 3.7% higher at 0.84 pence each on Friday morning in London.

This fundraise comes after Provexis in December raised GBP1.0 million through the placing of 133.3 million shares at 0.75p each.

The Reading-based company stated it will use the total amount raised to support its international growth plans as it highlighted a new production run for its Fruitflow+ Omega-3 heart-health dietary supplement product is in the process of being commissioned.

Provexis noted a director intends to participate in the placing through the subscription for 1.67 million shares for a total of GBP12,500 but did not disclose the name of the director.

By Ife Taiwo; ifetaiwo@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 Dec 2009 08:49

Small caps round-up: Landore Resources, TXO, Aortech...

Shares in Landore Resources jumped after the Canadian miner said it made a 'significant gold discovery' in its Junior Lake property in the province of Ontario. Shares in Texas-focused oil and gas firm TXO slumped after it said oil production in the six months to September 30 fell to 13,221 barrels

Read more
3 Nov 2009 12:16

Small cap round-up: Provexis, Puricore, Sirius, Sopheon, Spiritel

Food technology group Provexis says it has been told that the European Commission review into the health claim wording for its Fruitflow anti-thrombatic technology for use on consumer products is now in "an advanced stage". Puricore's third quarter sales rose 25% to $10.8m, with the nine month tot

Read more
11 Aug 2009 09:30

Provexis surges on Crohn's disease trial

Provexis, the life-science business, has begun a clinical trial for its NSP#3G plantain medical food for Crohn's disease patients. "With the trial now starting and combined with recently obtained healthy human data, the Company will now commence seeking to identify potential global license or co-de

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.